|
QLGN Qualigen Therapeutics Inc 1460702 |
| Income Statement |
|
Net Income
|
form10-q
|
-1,794,060 |
| Balance Sheet |
|
Current Assets
|
2,312,994 |
|
Assets
|
2,312,994 |
|
Current Liabilities
|
4,453,845 |
|
Liabilities
|
4,453,845 |
|
Equity
|
-2,140,851 |
|
Shares Out
|
27,022,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-4,057,980 |
|
Investing Cash Flow
|
-900,000 |
| Market Analysis |
Market Cap
|
4,898,171 |
|
Price
|
3.09 |
|
BVPS
|
0.11 |
|
PB
|
29.71 |
|
EPS
|
-1.75 |
|
PS
|
0.07 |
|
FCF
|
-4,957,980 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view QLGN documents filed with the SEC.
QLGN Filings
Clear
